Vaxcyte's GAAP loss for 2021 was $100.077 million, up 12.2% from $89.217 million the previous year.
Vaxcyte's GAAP loss for 2021 was $100.077 million, up 12.2% from $89.217 million the previous year.
Vaxcyte reported for 2021
Vaxcyte's GAAP loss for 2021 was $100.077 million, up 12.2% from $89.217 million the previous year. Source: 
investors.vaxcyte.com
investors.vaxcyte.com News feed
English (US) 